Regeneron Secures $407M Jury Verdict in Major Antitrust Win
2 minute read | May.16.2025

This verdict will ensure that patients continue to have access to Regeneron’s lifesaving, cholesterol-reducing drug Praluent.
2 minute read | May.16.2025
This verdict will ensure that patients continue to have access to Regeneron’s lifesaving, cholesterol-reducing drug Praluent.
1 minute read | April.01.2025
2 minute read | March.19.2025
1 minute read | March.03.2025
2 minute read | February.19.2025
3 minute read | January.30.2025
1 minute read | January.27.2025
2 minute read | December.13.2024